Followers | 2 |
Posts | 1231 |
Boards Moderated | 0 |
Alias Born | 08/04/2017 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, September 21, 2022 10:35:46 AM
Recent CMPX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 12:49:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 12:00:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:00:18 PM
- Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/12/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:07:16 PM
- Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference • GlobeNewswire Inc. • 08/07/2024 12:00:00 PM
- Compass Therapeutics Completes Patient Enrollment in COMPANION-002, a Randomized Study of CTX-009 in Combination with Paclitaxel, and Provides an Update on the Development Plan in Biliary Tract Cancer • GlobeNewswire Inc. • 08/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 12:32:02 PM
- Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/30/2024 12:00:00 PM
- Compass Therapeutics Announces CEO Transition • GlobeNewswire Inc. • 05/28/2024 08:10:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 08:09:10 PM
- Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual Meet • GlobeNewswire Inc. • 05/23/2024 09:05:00 PM
- Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 12:01:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 12:00:36 PM
- Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously Treated • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid Tumors • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference • GlobeNewswire Inc. • 04/12/2024 12:00:00 PM
- Compass Therapeutics to Participate in the Stifel Targeted Oncology Days • GlobeNewswire Inc. • 04/10/2024 12:00:00 PM
- Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/09/2024 04:00:00 PM
- Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/21/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 02:12:03 PM
- Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
- Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical Trial • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM